Paul A. Volberding, MD
Paul A. Volberding, MD, is a professor in the Department of Medicine and director of the Center for AIDS Research at the University of California, San Francisco (UCSF) and the Gladstone Institute of Virology and Immunology; and served until 2012 as vice chair of the Department of Medicine. He was appointed director of the AIDS Research Institute at UCSF and director of research for Global Health Sciences in 2012. Dr. Volberding served as director of the Positive Health Program at San Francisco General Hospital (SFGH) for 20 years. He received his undergraduate and medical degrees at the University of Chicago and the University of Minnesota, respectively, and finished training at the University of Utah and at UCSF, where he studied for two years as a research fellow in the virology laboratory of Dr. Jay Levy, later a co-discoverer of HIV.
Dr. Volberding’s professional activities centered for many years at SFGH, where he established a model program of AIDS patient care, research, and professional education. His research career began with investigations of HIV-related malignancies, especially Kaposi's sarcoma. His primary research focus, however, shifted to clinical trials of antiretroviral drugs. He has been instrumental in testing many compounds, but is best known for groundbreaking trials establishing standards of care for the use of zidovudine in asymptomatic HIV infection and for continuous service on the two major guidelines panels for antiretroviral therapy.
Dr. Volberding has written many research and review articles. He is co-editor in chief of the Journal of Acquired Immune Deficiency Syndromes, is the founder and chair of the board of the International AIDS Society–USA, and has served as president of the International AIDS Society and the HIV Medicine Association. He is the co-editor of Global HIV/AIDS Medicine, the extensively rewritten follow-up to The Medical Management of AIDS, formerly the most widely used textbook of HIV medicine. He was elected a member of the Institute of Medicine of the National Academy of Sciences in 1999 and is a fellow of the American College of Physicians, the Infectious Diseases Society of America, and the American Association for the Advancement of Sciences.